Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The new chart & the 450 days duration % numbers.

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Apr 30, 2023 8:34am

156 Views

Post# 35421426

RE:RE:RE:RE:RE:RE:The new chart & the 450 days duration % numbers.

Well, I have no idea how long they can hold out for? Another qtr and that would get them thru the next QTR update, and the AGM. By then we might have BTD and perhaps a JV partner? But then they'd need cash IF that doesn't happen. The way the stock is behaving says something happens sooner on cash piece though...

<< Previous

Bullboard Posts

Next >>

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity